Related Experiment Video
Updated: Jun 16, 2026

Tibial Nerve Transection - A Standardized Model for Denervation-induced Skeletal Muscle Atrophy in Mice
Published on: November 3, 2013
Prolonged vastus lateralis denervation after botulinum toxin type A injection
John W Dunne1, Barbara J Singer, Peter L Silbert
1Department of Neurology, Royal Perth Hospital, Perth, Australia.
Botulinum toxin (BoNT) injections for knee pain may cause longer muscle denervation than expected. Needle electromyography revealed persistent neuromuscular effects in patients months after treatment, differing from animal study predictions.
Area of Science:
- Neurology
- Musculoskeletal Medicine
- Biologics
Background:
- Botulinum toxin (BoNT) injections are used to treat muscle imbalances.
- BoNT typically causes reversible neuromuscular blockade, with recovery expected within 12 weeks in animal models.
Purpose of the Study:
- To investigate the duration of neuromuscular effects after BoNT injection in the vastus lateralis (VL) muscle.
- To compare clinical findings with established animal model recovery timelines.
Main Methods:
- Needle electromyography (EMG) was performed on 10 subjects.
- Subjects had received a single BoNT injection in the VL muscle 5-19 months prior for chronic anterior knee pain.
- EMG assessed insertional activity, spontaneous activity, recruitment, and motor unit action potentials in injected versus non-injected VL muscles.
Main Results:
- All 10 subjects demonstrated clear differences between injected and non-injected VL muscles.
- These differences correlated with the time elapsed since BoNT injection.
- Evidence of persisting denervation was observed in the BoNT-A injected VL muscle, extending beyond the expected recovery period from animal studies.
Conclusions:
- Clinical evidence suggests prolonged denervation following BoNT injection of the vastus lateralis muscle in humans.
- The duration of neuromuscular blockade in humans may exceed that observed in animal experimental models.
- Further research is warranted to understand the long-term implications of BoNT-induced denervation in clinical applications.
Related Concept Videos
Botulism
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Tetanus
Skeletal Muscle Relaxants: Therapeutic Uses
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
